circRNA basic information
circBase ID: -
Name: hsa_circ_AR
Synonym: circAR-E2E4
Host Gene: AR
Genomic location(hg19): -
Genomic location(hg38): -
Subcellular localization: not tested
 
 
 
 
 
 
 
Disease basic information
MONDO ID:
0005494
MONDO name: triple-negative breast carcinoma
Disease details: triple-negative breast cancer / TNBC
Disease DO ID:
0060081
Disease MeSH ID:
D064726
Disease NCIt ID:
C71732
Disease ICD11 ID:
-
Disease OMIM ID:
-
Species: Human
Species details: Homo sapiens
Tissue specimen:

subcutaneous prostate cancer transplantation tumors

Cell lines:

MDA-MB-231; MDA-MB-468; VCap

In vivo animal model:

cell line-derived xenograft

circRNA-disease information
Expression pattern:
UP
Associated gene: STAT3, AR
Associated microRNA: miR-665, miR-671-5p
Biological function: inhibits TNBC cell proliferation
Molecular mechanism: circAR-E2E4 sponges miR-665 (and miR-671-5p) and positively regulates STAT3; circAR-E2E4 is regulated by AR.
Biological pathway or process:

proliferation (inhibits); ceRNA regulation (other)

Detected method:
Q
Validation methods:

Back-Splice Junction PCR / divergent primers PCR; RNase R Treatment; Sanger Sequencing; RT-qPCR; RNA Pull-Down; Transfection; CCK8; Western Blot; In Vivo Animal Model; Bioinformatics Analysis

Clinical significance:

circAR-E2E4 has the potential to be a promising diagnostic, prognostic, and therapeutic target in TNBC

Description:

circAR-E2E4 (from the AR gene) promotes TNBC cell proliferation and is positively regulated by AR. Mechanistically, circAR-E2E4 acts as a miRNA sponge (miR-665/miR-671-5p), and circAR-E2E4 knockdown decreases STAT3 mRNA/protein, supporting a circAR-E2E4-miR-665-STAT3 regulatory axis in TNBC.

Confidence score:

0.7164

Other information
Title:

circAR-E2E4-miR-665-STAT3 axis is a potential regulatory network in triple-negative breast cancer.

Journal: Heliyon
Published: 2023
PubMed ID: 36691537
Study type:

combined biological and clinical study

Data availability: Data will be made available on request.
Code availability: -